latest news releases from the newsroom
North American Galvanizing & Coatings, Inc.
North American Galvanizing & Coatings Reports Record Second Quarter 2008 Earnings
TULSA, Okla., July 21, 2008 (PRIME NEWSWIRE) -- North American Galvanizing & Coatings, Inc. (Nasdaq:NGA) announced today record earnings for the first six months and the second quarter of 2008. The second quarter of 2008 is the Company's tenth consecutive quarter of record earnings.
Goodwin Biotechnology Incorporated
Goodwin Biotechnology's Manufactured Melanin-Binding Antibody Used in Successful Melanoma Trial
PLANTATION, Fla., July 21, 2008 (PRIME NEWSWIRE) -- Goodwin Biotechnology Inc. (GBI) today announced that the melanin-binding IgM antibody manufactured by the company was used in a successful Phase I clinical trial for the treatment of melanoma. The encouraging results, conducted by Pain Therapeutics, Inc. and its collaborators, were announced earlier this month. GBI was selected to develop the process and produce the preclinical and clinical material for this and future trials.